Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback